Clinical Trials
4
Active:3
Completed:0
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)
Phase 2
Recruiting
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Interventions
- First Posted Date
- 2022-07-25
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Belgian Group of Digestive Oncology
- Target Recruit Count
- 134
- Registration Number
- NCT05472259
- Locations
- 🇧🇪
AZ St-Lucas, Brugge, West-Vlaanderen, Belgium
🇧🇪UZ Antwerpen, Antwerp, Belgium
🇧🇪AZ Imelda, Bonheiden, Belgium
A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma
Phase 3
Active, not recruiting
- Conditions
- Small Bowel Adenocarcinoma
- Interventions
- Drug: Fluoropyrimidine
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Belgian Group of Digestive Oncology
- Target Recruit Count
- 30
- Registration Number
- NCT04257461
- Locations
- 🇧🇪
AZ Turnhout, Turnhout, Antwerpen, Belgium
🇧🇪Onze-Lieve-Vrouw Ziekenhuis Aalst, Aalst, Oost-Vlaanderen, Belgium
🇧🇪AZ St-Lucas, Gent, Oost-Vlaanderen, Belgium
News
No news found